List of Tables
Table 1. Global Biologics and Biosimilars Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Interferon
Table 4. Key Players of Insulin
Table 5. Key Players of Vaccines
Table 6. Key Players of Others
Table 7. Global Biologics and Biosimilars Market Size Growth Rate by Therapeutic Area (US$ Million): 2021 vs 2025 vs 2032
Table 8. Key Players of Oncology
Table 9. Key Players of Autoimmune Diseases
Table 10. Key Players of Endocrinology & Diabetes
Table 11. Key Players of Hematology
Table 12. Key Players of Other
Table 13. Global Biologics and Biosimilars Market Size Growth Rate by Route of Administration (US$ Million): 2021 vs 2025 vs 2032
Table 14. Key Players of Injectable
Table 15. Key Players of Inhalable Formulations
Table 16. Key Players of Oral Biologics
Table 17. Global Biologics and Biosimilars Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 18. Global Biologics and Biosimilars Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Biologics and Biosimilars Market Size by Region (US$ Million), 2021–2026
Table 20. Global Biologics and Biosimilars Market Share by Region (2021–2026)
Table 21. Global Biologics and Biosimilars Forecasted Market Size by Region (US$ Million), 2027–2032
Table 22. Global Biologics and Biosimilars Market Share by Region (2027–2032)
Table 23. Biologics and Biosimilars Market Trends
Table 24. Biologics and Biosimilars Market Drivers
Table 25. Biologics and Biosimilars Market Challenges
Table 26. Biologics and Biosimilars Market Restraints
Table 27. Global Biologics and Biosimilars Revenue by Players (US$ Million), 2021–2026
Table 28. Global Biologics and Biosimilars Market Share by Players (2021–2026)
Table 29. Global Top Biologics and Biosimilars Players by Tier (Tier 1, Tier 2, and Tier 3), based on Biologics and Biosimilars Revenue, 2025
Table 30. Ranking of Global Top Biologics and Biosimilars Companies by Revenue (US$ Million) in 2025
Table 31. Global 5 Largest Players Market Share by Biologics and Biosimilars Revenue (CR5 and HHI), 2021–2026
Table 32. Global Key Players of Biologics and Biosimilars, Headquarters and Area Served
Table 33. Global Key Players of Biologics and Biosimilars, Products and Applications
Table 34. Global Key Players of Biologics and Biosimilars, Date of General Availability (GA)
Table 35. Mergers and Acquisitions, Expansion Plans
Table 36. Global Biologics and Biosimilars Market Size by Type (US$ Million), 2021–2026
Table 37. Global Biologics and Biosimilars Revenue Market Share by Type (2021–2026)
Table 38. Global Biologics and Biosimilars Forecasted Market Size by Type (US$ Million), 2027–2032
Table 39. Global Biologics and Biosimilars Revenue Market Share by Type (2027–2032)
Table 40. Global Biologics and Biosimilars Market Size by Application (US$ Million), 2021–2026
Table 41. Global Biologics and Biosimilars Revenue Market Share by Application (2021–2026)
Table 42. Global Biologics and Biosimilars Forecasted Market Size by Application (US$ Million), 2027–2032
Table 43. Global Biologics and Biosimilars Revenue Market Share by Application (2027–2032)
Table 44. North America Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. North America Biologics and Biosimilars Market Size by Country (US$ Million), 2021–2026
Table 46. North America Biologics and Biosimilars Market Size by Country (US$ Million), 2027–2032
Table 47. Europe Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 48. Europe Biologics and Biosimilars Market Size by Country (US$ Million), 2021–2026
Table 49. Europe Biologics and Biosimilars Market Size by Country (US$ Million), 2027–2032
Table 50. Asia-Pacific Biologics and Biosimilars Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 51. Asia-Pacific Biologics and Biosimilars Market Size by Region (US$ Million), 2021–2026
Table 52. Asia-Pacific Biologics and Biosimilars Market Size by Region (US$ Million), 2027–2032
Table 53. Latin America Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 54. Latin America Biologics and Biosimilars Market Size by Country (US$ Million), 2021–2026
Table 55. Latin America Biologics and Biosimilars Market Size by Country (US$ Million), 2027–2032
Table 56. Middle East & Africa Biologics and Biosimilars Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 57. Middle East & Africa Biologics and Biosimilars Market Size by Country (US$ Million), 2021–2026
Table 58. Middle East & Africa Biologics and Biosimilars Market Size by Country (US$ Million), 2027–2032
Table 59. Roche Company Details
Table 60. Roche Business Overview
Table 61. Roche Biologics and Biosimilars Product
Table 62. Roche Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 63. Roche Recent Development
Table 64. Amgen Company Details
Table 65. Amgen Business Overview
Table 66. Amgen Biologics and Biosimilars Product
Table 67. Amgen Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 68. Amgen Recent Development
Table 69. AbbVie Company Details
Table 70. AbbVie Business Overview
Table 71. AbbVie Biologics and Biosimilars Product
Table 72. AbbVie Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 73. AbbVie Recent Development
Table 74. Sanofi Company Details
Table 75. Sanofi Business Overview
Table 76. Sanofi Biologics and Biosimilars Product
Table 77. Sanofi Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 78. Sanofi Recent Development
Table 79. Johnson & Johnson Company Details
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Biologics and Biosimilars Product
Table 82. Johnson & Johnson Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 83. Johnson & Johnson Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Biologics and Biosimilars Product
Table 87. Pfizer Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 88. Pfizer Recent Development
Table 89. Novo Nordisk Company Details
Table 90. Novo Nordisk Business Overview
Table 91. Novo Nordisk Biologics and Biosimilars Product
Table 92. Novo Nordisk Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 93. Novo Nordisk Recent Development
Table 94. Eli Lilly Company Details
Table 95. Eli Lilly Business Overview
Table 96. Eli Lilly Biologics and Biosimilars Product
Table 97. Eli Lilly Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 98. Eli Lilly Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Biologics and Biosimilars Product
Table 102. Novartis Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 103. Novartis Recent Development
Table 104. Merck Company Details
Table 105. Merck Business Overview
Table 106. Merck Biologics and Biosimilars Product
Table 107. Merck Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 108. Merck Recent Development
Table 109. Biogen Company Details
Table 110. Biogen Business Overview
Table 111. Biogen Biologics and Biosimilars Product
Table 112. Biogen Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 113. Biogen Recent Development
Table 114. Celltrion Company Details
Table 115. Celltrion Business Overview
Table 116. Celltrion Biologics and Biosimilars Product
Table 117. Celltrion Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 118. Celltrion Recent Development
Table 119. Sobi Company Details
Table 120. Sobi Business Overview
Table 121. Sobi Biologics and Biosimilars Product
Table 122. Sobi Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 123. Sobi Recent Development
Table 124. 3SBIO Company Details
Table 125. 3SBIO Business Overview
Table 126. 3SBIO Biologics and Biosimilars Product
Table 127. 3SBIO Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 128. 3SBIO Recent Development
Table 129. Changchun High Tech Company Details
Table 130. Changchun High Tech Business Overview
Table 131. Changchun High Tech Biologics and Biosimilars Product
Table 132. Changchun High Tech Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 133. Changchun High Tech Recent Development
Table 134. Kanghong Pharma Company Details
Table 135. Kanghong Pharma Business Overview
Table 136. Kanghong Pharma Biologics and Biosimilars Product
Table 137. Kanghong Pharma Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 138. Kanghong Pharma Recent Development
Table 139. Innovent Biologics Company Details
Table 140. Innovent Biologics Business Overview
Table 141. Innovent Biologics Biologics and Biosimilars Product
Table 142. Innovent Biologics Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 143. Innovent Biologics Recent Development
Table 144. Gan&Lee Company Details
Table 145. Gan&Lee Business Overview
Table 146. Gan&Lee Biologics and Biosimilars Product
Table 147. Gan&Lee Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 148. Gan&Lee Recent Development
Table 149. Tonghua Dongbao Company Details
Table 150. Tonghua Dongbao Business Overview
Table 151. Tonghua Dongbao Biologics and Biosimilars Product
Table 152. Tonghua Dongbao Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 153. Tonghua Dongbao Recent Development
Table 154. United Laboratory Company Details
Table 155. United Laboratory Business Overview
Table 156. United Laboratory Biologics and Biosimilars Product
Table 157. United Laboratory Revenue in Biologics and Biosimilars Business (US$ Million), 2021–2026
Table 158. United Laboratory Recent Development
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
Table 162. Authors List of This Report
List of Figures
Figure 1. Biologics and Biosimilars Picture
Figure 2. Global Biologics and Biosimilars Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Biologics and Biosimilars Market Share by Type: 2025 vs 2032
Figure 4. Monoclonal Antibodies Features
Figure 5. Interferon Features
Figure 6. Insulin Features
Figure 7. Vaccines Features
Figure 8. Others Features
Figure 9. Global Biologics and Biosimilars Market Size Comparison by Therapeutic Area (US$ Million), 2021–2032
Figure 10. Oncology Features
Figure 11. Autoimmune Diseases Features
Figure 12. Endocrinology & Diabetes Features
Figure 13. Hematology Features
Figure 14. Other Features
Figure 15. Global Biologics and Biosimilars Market Size Comparison by Route of Administration (US$ Million), 2021–2032
Figure 16. Injectable Features
Figure 17. Inhalable Formulations Features
Figure 18. Oral Biologics Features
Figure 19. Global Biologics and Biosimilars Market Size by Application (US$ Million), 2021–2032
Figure 20. Global Biologics and Biosimilars Market Share by Application: 2025 vs 2032
Figure 21. Hospital Case Studies
Figure 22. Retail Pharmacy Case Studies
Figure 23. Other Case Studies
Figure 24. Biologics and Biosimilars Report Years Considered
Figure 25. Global Biologics and Biosimilars Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 26. Global Biologics and Biosimilars Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 27. Global Biologics and Biosimilars Market Share by Region: 2025 vs 2032
Figure 28. Global Biologics and Biosimilars Market Share by Players in 2025
Figure 29. Global Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 30. The Top 10 and 5 Players Market Share by Biologics and Biosimilars Revenue in 2025
Figure 31. North America Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. North America Biologics and Biosimilars Market Share by Country (2021–2032)
Figure 33. United States Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Canada Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Europe Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Europe Biologics and Biosimilars Market Share by Country (2021–2032)
Figure 37. Germany Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. France Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. U.K. Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Italy Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Russia Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Ireland Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Asia-Pacific Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Asia-Pacific Biologics and Biosimilars Market Share by Region (2021–2032)
Figure 45. China Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Japan Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. South Korea Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Southeast Asia Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. India Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Australia & New Zealand Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Latin America Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Latin America Biologics and Biosimilars Market Share by Country (2021–2032)
Figure 53. Mexico Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Brazil Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. Middle East & Africa Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Middle East & Africa Biologics and Biosimilars Market Share by Country (2021–2032)
Figure 57. Israel Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 58. Saudi Arabia Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 59. UAE Biologics and Biosimilars Market Size YoY Growth (US$ Million), 2021–2032
Figure 60. Roche Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 61. Amgen Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 62. AbbVie Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 63. Sanofi Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 64. Johnson & Johnson Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 65. Pfizer Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 66. Novo Nordisk Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 67. Eli Lilly Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 68. Novartis Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 69. Merck Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 70. Biogen Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 71. Celltrion Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 72. Sobi Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 73. 3SBIO Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 74. Changchun High Tech Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 75. Kanghong Pharma Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 76. Innovent Biologics Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 77. Gan&Lee Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 78. Tonghua Dongbao Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 79. United Laboratory Revenue Growth Rate in Biologics and Biosimilars Business (2021–2026)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
